Holen Sie sich die Stockscreener-App
46.35
1.09%
-0.51
Vorhandelsmarkt:
46.22
-0.13
-0.28%
Gsk Plc Adr Aktie (GSK) Neueste Nachrichten
GSK PLC Sponsored ADR (NYSE:GSK) Given Average Rating of "Hold" by Analysts - MarketBeat
Arkadios Wealth Advisors Acquires 6,734 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR Plans Quarterly Dividend of $0.42 (NYSE:GSK) - MarketBeat
Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility - GlobeNewswire Inc.
GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology - Morningstar
GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View - TradingView
Whittier Trust Co. Sells 5,805 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep - Sahm
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK) - The Globe and Mail
GSK PLC Sponsored ADR $GSK Shares Acquired by Ethic Inc. - MarketBeat
ETFs Investing in GSK plc Sponsored ADR Stocks - TradingView
Stanley Laman Group Ltd. Decreases Stock Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat
UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment - Sahm
The Best Healthcare Stocks to Buy - Morningstar
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Sahm
Rep. Val T. Hoyle Sells GSK PLC Sponsored ADR (NYSE:GSK) Stock - MarketBeat
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Gilead Resolves Patent Litigations for HIV Treatment Biktarvy - The Globe and Mail
AstraZeneca Upgraded, Home Depot Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Why GSK (GSK) is a Top Value Stock for the Long-Term - sharewise.com
GSK PLC (GSK) Stock Price, Trades & News - GuruFocus
AnaptysBio Charts Path To Split Into Two Public Companies By 2026 - Sahm
Park Place Capital Corp Raises Stock Position in GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR $GSK Shares Bought by Farther Finance Advisors LLC - Defense World
GlaxoSmithKline (GSK) Gets a Hold from Barclays - The Globe and Mail
Sound Income Strategies LLC Has $16.56 Million Position in GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR $GSK Shares Sold by Clean Yield Group - MarketBeat
The 10 Best Companies to Invest in Now - Morningstar
Amgen Expands US Manufacturing Network Amid New Tariff Policy - Sahm
TD Private Client Wealth LLC Raises Stock Position in GSK PLC Sponsored ADR $GSK - MarketBeat
Pneumococcal Vaccine Market Opportunities and Strategies to 2034 - GlobeNewswire Inc.
Miller Howard Investments Inc. NY Purchases 13,023 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock? - The Globe and Mail
Why GSK (GSK) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Here's Why GSK (GSK) is a Strong Growth Stock - sharewise.com
Rhumbline Advisers Increases Holdings in GSK PLC Sponsored ADR $GSK - Defense World
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
1.05%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):